Health Care & Life Sciences » Pharmaceuticals | Komipharm International Co. Ltd.

Komipharm International Co. Ltd. | Mutual Funds

Mutual Funds that own Komipharm International Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total International Stock Index Fund
446,482
0.81%
0
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
388,670
0.7%
0
0.02%
09/05/2018
Vanguard Developed Markets Index Fund
182,566
0.33%
0
0%
07/31/2018
Market Vectors - Agribusiness ETF
101,240
0.18%
-390
0.28%
09/05/2018
Vanguard FTSE All World (ex-US) Small Cap
84,563
0.15%
6,067
0.03%
07/31/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
76,560
0.14%
0
0.02%
09/05/2018
Mirae Asset TIGER Health Care ETF
66,758
0.12%
16,646
1.03%
04/30/2018
Government Pension Fund - Global (The)
66,320
0.12%
-123,564
0%
12/31/2017
DFA Emerging Markets Core Equity Portfolio
59,209
0.11%
0
0.01%
04/30/2018
Vanguard Pacific Stock Index Fund
35,502
0.06%
0
0.01%
07/31/2018

About Komipharm International Co.

View Profile
Address
17 Gyeongje-ro
Siheung GY 15094
Korea, Republic Of
Employees -
Website http://www.komipharm.com
Updated 09/14/2018
Komipharm International Co., Ltd. engages in the development and manufacturing of natural food additives, veterinary vaccines and pharmaceuticals. It operates through Animal Health and Pharmaceuticals divisions. The Animal Health division manufactures veterinary products such as vaccines, antibiotics, antibacterial, nutrition, metabolic, immune boosters, digestive enzymes, expectorant, hormone, skin disease, anesthetic, antipyretic-analgesics and organic acid for being used to livestock, aqua and pet animals.